JP2018506302A5 - - Google Patents

Download PDF

Info

Publication number
JP2018506302A5
JP2018506302A5 JP2017558784A JP2017558784A JP2018506302A5 JP 2018506302 A5 JP2018506302 A5 JP 2018506302A5 JP 2017558784 A JP2017558784 A JP 2017558784A JP 2017558784 A JP2017558784 A JP 2017558784A JP 2018506302 A5 JP2018506302 A5 JP 2018506302A5
Authority
JP
Japan
Prior art keywords
hs2dab
inventors
single domain
domain antibody
imgt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017558784A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018506302A (ja
JP6871866B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/052136 external-priority patent/WO2016124568A1/en
Publication of JP2018506302A publication Critical patent/JP2018506302A/ja
Publication of JP2018506302A5 publication Critical patent/JP2018506302A5/ja
Application granted granted Critical
Publication of JP6871866B2 publication Critical patent/JP6871866B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017558784A 2015-02-03 2016-02-02 抗rho gtpaseコンホーメーションシングルドメイン抗体及びその使用 Expired - Fee Related JP6871866B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15305160 2015-02-03
EP15305160.2 2015-02-03
PCT/EP2016/052136 WO2016124568A1 (en) 2015-02-03 2016-02-02 Anti-rho gtpase conformational single domain antibodies and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020096921A Division JP7095019B2 (ja) 2015-02-03 2020-06-03 抗rho gtpaseコンホーメーションシングルドメイン抗体及びその使用

Publications (3)

Publication Number Publication Date
JP2018506302A JP2018506302A (ja) 2018-03-08
JP2018506302A5 true JP2018506302A5 (enExample) 2018-12-27
JP6871866B2 JP6871866B2 (ja) 2021-05-19

Family

ID=52464303

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017558784A Expired - Fee Related JP6871866B2 (ja) 2015-02-03 2016-02-02 抗rho gtpaseコンホーメーションシングルドメイン抗体及びその使用
JP2020096921A Expired - Fee Related JP7095019B2 (ja) 2015-02-03 2020-06-03 抗rho gtpaseコンホーメーションシングルドメイン抗体及びその使用
JP2022100217A Pending JP2022130514A (ja) 2015-02-03 2022-06-22 抗rho gtpaseコンホーメーションシングルドメイン抗体及びその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020096921A Expired - Fee Related JP7095019B2 (ja) 2015-02-03 2020-06-03 抗rho gtpaseコンホーメーションシングルドメイン抗体及びその使用
JP2022100217A Pending JP2022130514A (ja) 2015-02-03 2022-06-22 抗rho gtpaseコンホーメーションシングルドメイン抗体及びその使用

Country Status (5)

Country Link
US (3) US10544210B2 (enExample)
EP (1) EP3253791A1 (enExample)
JP (3) JP6871866B2 (enExample)
CN (2) CN114133450B (enExample)
WO (1) WO2016124568A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10544210B2 (en) * 2015-02-03 2020-01-28 Inserm (Institut National De La Sante Et De La Recherche Medicale) Anti-Rho GTPase conformational single domain antibodies and uses thereof
WO2020080490A1 (ja) * 2018-10-17 2020-04-23 国立大学法人東京大学 ペプチドライブラリーの製造方法
US12415869B2 (en) 2019-04-22 2025-09-16 University Of Washington Chemically induced protein dimerization systems
WO2020254619A1 (en) * 2019-06-20 2020-12-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti- protease nexin-1 conformational single domain antibodies and uses thereof
WO2021078359A1 (en) * 2019-10-21 2021-04-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of inhibitors of cubilin for the treatment of chronic kidney diseases
GB202005876D0 (en) * 2020-04-22 2020-06-03 Univ Dundee Protein degradation
AU2021275489A1 (en) * 2020-05-20 2022-12-01 Centre National De La Recherche Scientifique - Cnrs - Single domain antibodies and their use in cancer therapies
CN114736302B (zh) * 2022-05-12 2022-10-25 诺赛联合(北京)生物医学科技有限公司 一种干细胞无血清培养基
CN114605554B (zh) * 2022-05-12 2022-07-05 诺赛联合(北京)生物医学科技有限公司 一种间充质干细胞培养基
CN116042614A (zh) * 2022-09-20 2023-05-02 中国人民解放军海军军医大学 RhoD抑制剂在防治寨卡病毒感染中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI903489A7 (fi) 1988-11-11 1990-07-10 Medical Res Council Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö
DE69334275D1 (de) 1992-08-21 2009-05-20 Univ Bruxelles Immunoglobuline ohne Leichtkette
EP0739981A1 (en) 1995-04-25 1996-10-30 Vrije Universiteit Brussel Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
AU765703B2 (en) 1998-03-27 2003-09-25 Bruce J. Bryan Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
US20060073141A1 (en) 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
CA2651805A1 (en) * 2006-05-12 2007-11-22 The Queen's University Of Belfast Therapy
EP2287197A1 (en) * 2009-08-21 2011-02-23 Pierre Fabre Medicament Anti-cMET antibody and its use for the detection and the diagnosis of cancer
CN102399288B (zh) * 2011-10-19 2013-06-05 山西德丰信成生物科技有限公司 针对免疫球蛋白Fc段的单域重链抗体
JP2016528176A (ja) * 2013-06-06 2016-09-15 ジェイ ローランズ、デビッド シングルドメイン抗体ディスプレイ
US10544210B2 (en) * 2015-02-03 2020-01-28 Inserm (Institut National De La Sante Et De La Recherche Medicale) Anti-Rho GTPase conformational single domain antibodies and uses thereof

Similar Documents

Publication Publication Date Title
JP2019164961A5 (enExample)
JP2018186811A5 (enExample)
JP2017179103A5 (enExample)
JP2020049413A5 (enExample)
JP2019210167A5 (enExample)
JP2017203885A5 (enExample)
JP2020031580A5 (enExample)
JP2017020017A5 (enExample)
JP2016157119A5 (enExample)
JP2019073673A5 (enExample)
JP2018513162A5 (enExample)
JP2020509061A5 (enExample)
JP2019106905A5 (enExample)
JP2020524126A5 (enExample)
JP2019014676A5 (enExample)
JP2018016713A5 (enExample)
JP2018012810A5 (enExample)
JP2018013520A5 (enExample)
JP2017001943A5 (enExample)
JP2017178739A5 (enExample)
JP2020035290A5 (enExample)
JP2019096401A5 (enExample)
JP2017122874A5 (enExample)
JP2020035289A5 (enExample)
JP2020021527A5 (enExample)